Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference

被引:18
|
作者
Lipton, Allan
Berenson, James R.
Body, Jean-Jacques
Boyce, Brendan F.
Bruland, Oyvind S.
Carducci, Michael A.
Cleeland, Charles S.
Clohisy, Denis R.
Coleman, Robert E.
Cook, Richard J.
Guise, Theresa A.
Pearse, Roger N.
Powles, Trevor J.
Rogers, Michael J.
Roodman, G. David
Smith, Matthew R.
Suva, Larry J.
Vessella, Robert L.
Weilbaecher, Katherine N.
King, Laura
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Hershey, PA 17033 USA
[2] Inst Myeloma & Bone Canc Res, W Hollywood, CA USA
[3] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium
[4] Univ Libre Bruxelles, Inst Jules Bordet, Dept Internal Med, Brussels, Belgium
[5] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA
[6] Norwegian Radium Hosp, Dept Oncol, Oslo, Norway
[7] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[8] Univ Texas, MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
[9] Univ Minnesota, Ctr Canc, Dept Orthoped Surg, Minneapolis, MN USA
[10] Weston Pk Hosp, Ctr Canc Res, Acad Unit Clin Oncol, Sheffield, S Yorkshire, England
[11] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
[12] Univ Virginia, Dept Endocrinol & Med, Charlottesville, VA USA
[13] Cornell Univ, Coll Med, Dept Med, Div Hematol Oncol, New York, NY USA
[14] Parkside Oncol Ctr, London, England
[15] Univ Aberdeen, Inst Med Sci, Bone Res Grp, Aberdeen, Scotland
[16] Univ Pittsburgh, Pittsburgh, PA USA
[17] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Hematol Oncol,Canc Ctr, Boston, MA USA
[18] Univ Arkansas Med Sci, Ctr Orthopaed Res, Little Rock, AR 72205 USA
[19] Univ Washington, Sch Med, Genitourinary Canc Res Lab, Seattle, WA USA
[20] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[21] Informed Commun Inc, Carlisle, MA USA
关键词
D O I
10.1158/1078-0432.CCR-06-1213
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The First Cambridge Conference on Advances in Treating Metastatic Bone Cancer, a symposium held in Cambridge, Massachusetts, October 28 to 29, 2005, was convened to discuss recent advances and research related to the natural history of bone metastases and skeletal complications, bone cancer biology, treatment of myeloma and other solid tumors, and treatment-induced bone loss. The conference format combined brief presentations with extended periods of discussion. The conclusions reached during the 2-day meeting are summarized in this article and presented in more detail in the individual articles and accompanying discussion sessions that comprise the conference proceedings.
引用
收藏
页码:6209S / 6212S
页数:4
相关论文
共 50 条
  • [21] Conference summary: First International Workshop on Animal Models of Prostate Cancer
    Waters, DJ
    Bostwick, DG
    Murphy, GP
    [J]. PROSTATE, 1998, 36 (01): : 47 - 48
  • [22] Development and validation of propeptide therapeutics for treating bone metastatic prostate cancer
    Salameh, Janelle W.
    Umbaugh, Charles S.
    Figueiredo, Marxa L.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [23] Innovations and challenges in renal cancer: Consensus statement from the first international conference
    Atkins, MB
    Avigan, DE
    Bukowski, RM
    Childs, RW
    Dutcher, JP
    Eisen, TG
    Figlin, RA
    Finke, JH
    Flanigan, RC
    George, DJ
    Goldberg, SN
    Gordon, MS
    Iliopoulos, O
    Kaelin, WG
    Linehan, WM
    Lipton, A
    Motzer, RJ
    Novick, AC
    Stadler, WM
    Teh, BT
    Yang, JC
    King, L
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6277S - 6281S
  • [24] Recent advances in the targeted fluorescent probes for the detection of metastatic bone cancer
    Wu, Peng
    Siegwart, Daniel J.
    Xiong, Hu
    [J]. SCIENCE CHINA-CHEMISTRY, 2021, 64 (08) : 1283 - 1296
  • [25] Recent advances in the targeted fluorescent probes for the detection of metastatic bone cancer
    Peng Wu
    Daniel JSiegwart
    Hu Xiong
    [J]. Science China(Chemistry), 2021, (08) - 1296
  • [26] Recent advances in the targeted fluorescent probes for the detection of metastatic bone cancer
    Peng Wu
    Daniel J. Siegwart
    Hu Xiong
    [J]. Science China Chemistry, 2021, 64 : 1283 - 1296
  • [27] Recent advances in the targeted fluorescent probes for the detection of metastatic bone cancer
    Peng Wu
    Daniel J.Siegwart
    Hu Xiong
    [J]. Science China Chemistry, 2021, 64 (08) : 1283 - 1296
  • [28] Recent advances in bone-targeted therapies of metastatic prostate cancer
    Deng, Xiyun
    He, Guangchun
    Liu, Junwen
    Luo, Feijun
    Peng, Xiaoning
    Tang, Shigang
    Gao, Zhiyong
    Lin, Qinlu
    Keller, Jill M.
    Yang, Tao
    Keller, Evan T.
    [J]. CANCER TREATMENT REVIEWS, 2014, 40 (06) : 730 - 738
  • [29] Recent advances in first-line treatment of metastatic colorectal cancer
    Fakih, Marwan
    [J]. COLORECTAL CANCER, 2012, 1 (02) : 111 - 114
  • [30] The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials
    Cheng, Xi
    Wei, Jinrong
    Ge, Qi
    Xing, Danlei
    Zhou, Xuefeng
    Qian, Yunzhu
    Jiang, Guoqin
    [J]. DRUG DELIVERY, 2021, 28 (01) : 37 - 53